Complete surgical myocardial revascularization in patients with declined renal functions: 12-month outcomes.
Cardiopulmonary bypass
Coronary artery bypass grafting
Kidney functions
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
29 09 2023
29 09 2023
Historique:
received:
23
06
2023
accepted:
12
09
2023
medline:
2
10
2023
pubmed:
29
9
2023
entrez:
29
9
2023
Statut:
epublish
Résumé
This retrospective observational study aimed to evaluate the feasibility and effectiveness of complete revascularization coronary artery bypass grafting (CABG) in patients with multi-vessel disease (MVD)-CAD and declined renal functions, addressing the knowledge gap regarding optimal treatment strategies and outcomes in this specific patient population. Between 2020 and 2022, a total of 58 patients underwent on-pump coronary artery bypass grafting surgery for complete myocardial revascularization in this study. To assess overall survival, Kaplan-Meier with the log-rank test was conducted for statistical analysis. The mean age of cohort was 60.7. The findings showed a high prevalence of medical conditions such as hypertension (50.0%), diabetes (50.0%), and anaemia (41.4%) among the participants. Intraoperatively, low cardiac output syndrome was reported in 5.2% of cases, while perioperative outcomes indicated a need for transfusions in 53.5% of cases and an in-hospital mortality rate of 3.4%. At the 12-month follow-up, no redo revascularization or renal replacement therapy was required, but cardiac mortality was 5.2% and all-cause mortality was 6.9%. The study concluded that complete revascularization is safe for these patients and highlights the potential benefits, emphasizing the need for further research in optimizing revascularization techniques for this population.
Identifiants
pubmed: 37773097
doi: 10.1186/s12872-023-03507-1
pii: 10.1186/s12872-023-03507-1
pmc: PMC10540422
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
484Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Cai Q, Mukku V, Ahmad M. Coronary artery disease in patients with chronic kidney disease: a clinical update. Curr Cardiol Rev. 2014;9:331–9.
doi: 10.2174/1573403X10666140214122234
Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int. 2006;70:2021–30.
doi: 10.1038/sj.ki.5001934
Liao G, Li Y, Bai L, et al. Revascularization vs. Conservative Medical Treatment in Patients With Chronic Kidney Disease and Coronary Artery Disease: a meta-analysis. Front Cardiovasc Med; 8. https://doi.org/10.3389/fcvm.2021.818958 . Epub ahead of print February 7, 2022.
Giustino G, Mehran R, Serruys PW, et al. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease. J Am Coll Cardiol. 2018;72:754–65.
doi: 10.1016/j.jacc.2018.05.057
Chan W, Ivanov J, Ko D, et al. Clinical outcomes of treatment by percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with chronic kidney disease undergoing index revascularization in Ontario. Can J Cardiol. 2014;30:S139.
doi: 10.1016/j.cjca.2014.07.732
Milojevic M, Head SJ, Mack MJ, et al. The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial. EuroIntervention. 2018;14:102–11.
doi: 10.4244/EIJ-D-17-00620
Gaba P, Gersh BJ, Ali ZA, et al. Complete versus incomplete coronary revascularization: definitions, assessment and outcomes. Nat Rev Cardiol. 2020;18:155–68.
doi: 10.1038/s41569-020-00457-5
Gössl M, Faxon DP, Bell MR, et al. Complete versus incomplete revascularization with coronary artery bypass graft or percutaneous intervention in stable coronary artery disease. Circulation. 2012;5:597–604.
Stevens LA, Manzi J, Levey AS, et al. Impact of creatinine calibration on performance of GFR estimating equations in a pooled individual patient database. Am J Kidney Dis. 2007;50:21–35.
doi: 10.1053/j.ajkd.2007.04.004
Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2013;3(1):19-62. https://doi.org/10.1038/kisup.2012.64 .
Kiziltepe U, Uysalel A, Corapcioglu T, et al. Effects of combined conventional and modified ultrafiltration in adult patients. Ann Thorac Surg. 2001;71:684–93.
doi: 10.1016/S0003-4975(00)02518-2
Garcia S, Sandoval Y, Roukoz H, et al. Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease. J Am Coll Cardiol. 2013;62:1421–31.
doi: 10.1016/j.jacc.2013.05.033
Rydén L, Sartipy U, Evans M, et al. Acute kidney injury after coronary artery bypass grafting and long-term risk of end-stage renal disease. Circulation. 2014;130:2005–11.
doi: 10.1161/CIRCULATIONAHA.114.010622